東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Cancer- Tomography." ]

切換: 標籤 | MARC模式 | ISBD

Applications of FDG PET in oncology ...

Fujii, Hirofumi.

FindBook

Google Book

Amazon

博客來

Applications of FDG PET in oncology = best clinical practice /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Applications of FDG PET in oncology/ edited by Hirofumi Fujii, Hiroyuki Nakamura, Seiei Yasuda.
其他題名:	best clinical practice /
其他作者:	Fujii, Hirofumi.
出版者:	Singapore :Springer Singapore : : 2021.,
面頁冊數:	vii, 147 p. :ill., digital ;24 cm.
內容註:	1 Overview -- 2 Lung cancer -- 3 Breast cancer -- 4 Head and neck cancer -- 5 Gastrointestinal cancer including GIST -- 6 Pancreatic cancer -- 7 Urological cancer -- 8 Malignant bone and soft tissue tumors -- 9 Skin cancer including malignant melanoma -- 10 Malignant lymphoma.
Contained By:	Springer Nature eBook
標題:	Tomography, Emission. -
電子資源:	https://doi.org/10.1007/978-981-15-8423-7
ISBN:	9789811584237

Applications of FDG PET in oncology = best clinical practice /
Applications of FDG PET in oncologybest clinical practice /[electronic resource] :edited by Hirofumi Fujii, Hiroyuki Nakamura, Seiei Yasuda. - Singapore :Springer Singapore :2021. - vii, 147 p. :ill., digital ;24 cm.

1 Overview -- 2 Lung cancer -- 3 Breast cancer -- 4 Head and neck cancer -- 5 Gastrointestinal cancer including GIST -- 6 Pancreatic cancer -- 7 Urological cancer -- 8 Malignant bone and soft tissue tumors -- 9 Skin cancer including malignant melanoma -- 10 Malignant lymphoma.

This book provides up-to-date guidance on the use of FDG PET to assess the biological activity and treatment response of a wide range of malignancies, including, for example, lung cancer, breast cancer, head and neck cancer, gastrointestinal cancer, and malignant lymphoma. In the era of precision medicine, numerous new anticancer agents, such as molecular targeted agents and immune checkpoint inhibitors, have been developed to improve outcomes in cancer patients. FDG PET plays a key role in evaluating the effects of these novel treatments because it can detect changes in the metabolic activity of tumors before any reduction in their size is visible on other imaging modalities. Accordingly, FDG PET is of prognostic as well as diagnostic value, and allows prompt changes in patient management. The book is written by expert clinicians from Japan, where the universal public health insurance system ensures that FDG PET is widely used in routine oncological practice and cancer screening. It represents an unrivaled and comprehensive resource that will be of value for all healthcare professionals in the field of clinical oncology.

ISBN: 9789811584237

Standard No.: 10.1007/978-981-15-8423-7doiSubjects--Topical Terms:

554356
Tomography, Emission.

LC Class. No.: RC270.3.T65

Dewey Class. No.: 616.99407575

Applications of FDG PET in oncology = best clinical practice /
LDR:02437nmm a2200325 a 4500 001 2236999
003 DE-He213
005 20201207124607.0
006 m d
007 cr nn 008maaau
008 211111s2021 si s 0 eng d
020 $a 9789811584237 $q (electronic bk.)
020 $a 9789811584220 $q (paper)
024 7 $a 10.1007/978-981-15-8423-7 $2 doi
035 $a 978-981-15-8423-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RC270.3.T65
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99407575 $2 23
090 $a RC270.3.T65 $b A652 2021
245 0 0 $a Applications of FDG PET in oncology $h [electronic resource] : $b best clinical practice / $c edited by Hirofumi Fujii, Hiroyuki Nakamura, Seiei Yasuda.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2021.
300 $a vii, 147 p. : $b ill., digital ; $c 24 cm.
505 0 $a 1 Overview -- 2 Lung cancer -- 3 Breast cancer -- 4 Head and neck cancer -- 5 Gastrointestinal cancer including GIST -- 6 Pancreatic cancer -- 7 Urological cancer -- 8 Malignant bone and soft tissue tumors -- 9 Skin cancer including malignant melanoma -- 10 Malignant lymphoma.
520 $a This book provides up-to-date guidance on the use of FDG PET to assess the biological activity and treatment response of a wide range of malignancies, including, for example, lung cancer, breast cancer, head and neck cancer, gastrointestinal cancer, and malignant lymphoma. In the era of precision medicine, numerous new anticancer agents, such as molecular targeted agents and immune checkpoint inhibitors, have been developed to improve outcomes in cancer patients. FDG PET plays a key role in evaluating the effects of these novel treatments because it can detect changes in the metabolic activity of tumors before any reduction in their size is visible on other imaging modalities. Accordingly, FDG PET is of prognostic as well as diagnostic value, and allows prompt changes in patient management. The book is written by expert clinicians from Japan, where the universal public health insurance system ensures that FDG PET is widely used in routine oncological practice and cancer screening. It represents an unrivaled and comprehensive resource that will be of value for all healthcare professionals in the field of clinical oncology.
650 0 $a Tomography, Emission. $3 554356
650 0 $a Cancer $x Tomography. $3 901452
650 1 4 $a Oncology. $3 751006
650 2 4 $a Imaging / Radiology. $3 891022
650 2 4 $a Cancer Research. $3 891172
700 1 $a Fujii, Hirofumi. $3 3488877
700 1 $a Nakamura, Hiroyuki. $3 2180432
700 1 $a Yasuda, Seiei. $3 3488878
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-15-8423-7
950 $a Medicine (SpringerNature-11650)